South China Venture Capital is a private equity investment fund management firm.
South China Venture Capital is a private equity investment fund management as the main business of professional investment management organization. Under the jurisdiction of the three branch of the fund management company: Shenzhen South China Invsetment Management Co.Ltd, South China (Tianjin) Equity Investment Fund Management Co. Ltd., Shenzhen Zhongnan Hongyuan Invsetment Management Co. Ltd.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 5, 2019
EpimAb Biotherapeutics
|
Series B | $74M | Biopharma | — |